The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity

• Main Authors: Eman Mostafa Hamed (Author), Ahmed R. N. Ibrahim (Author), Mohamed Hussein Meabed (Author), Ahmed M. Khalaf (Author), Doaa Mohamed El Demerdash (Author), Marwa O. Elgendy (Author), Haitham Saeed (Author), Heba F. Salem (Author), Hoda Rabea (Author)
• Format: Book
• Published: MDPI AG, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune thrombocytopenia (ITP) treatment has evolved recently. However, none of the treatments have only benefits without drawbacks. This study aimed to compare the clinical outcomes and adverse drug patterns of Eltrombopag, Romiplostim, Prednisolone + Azathioprine, High Dose-dexamethasone (HD-DXM) (...